Case Study

COVID-19 with Multiple Bacterial Co-infections: A Case Report

Sadia Saber
Bangladesh Medical College, Bangladesh
* Corresponding author
Samia Rashna Ahmed
Bangladesh Medical College, Bangladesh
Naz Yasmin
International Medical College, Bangladesh
Mohammed Tarek Alam
Bangladesh Medical College, Bangladesh
Abdul Basit Ibne Momen
Bangladesh Medical College, Bangladesh
Mohammad Monower Hossain
Bangladesh Medical College Hospital, Bangladesh
Rafa Faaria Alam
Bangladesh Medical College Hospital, Bangladesh
DOI icon 10.24018/ejmed.2021.3.1.646

Read Counter
1520

Downloads
735

Citations

Share

Article Sidebar

Submitted 2020-12-31
Published 2021-01-07

Read counter = 1520 times

Table of Contents

Article Main Content

Coronavirus disease 2019 (COVID-19) is a contagious disease which was first identified in Wuhan, China in December 2019. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for this ongoing pandemic worldwide. COVID-19 itself has a high mortality rate but in addition with bacterial co-infection, the risk of death amplifies much higher. The diagnosis of COVID-19 along with other respiratory co-infections can be a difficult task due to the similarities in their presentations. Here, we present a case of 60-years-old gentleman who was COVID-19 positive, co-infected with three types of bacterial pathogens, which were Mycobacterium tuberculosis, Enterobacter spp. and Pseudomonas. The patient was isolated and treated according to the pathogens’ culture sensitivity reports and was discharged when his condition improved and advised for routine follow-up. The source of the co-infection could not be identified and may have been hospital acquired. Therefore, every hospital should give utmost priority to infection prevention and control (IPC) strategies.

Keywords: COVID-19, Enterobacter, Pseudomonas, SARS-CoV-2

References

  1. World Health Organization, "Covid-19 Situation Report: 192," 30 July 2020. [Online]. Available: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200730-covid-19-sitrep-192.pdf?sfvrsn=5e52901f_4.
     Google Scholar
  2. Yang X, Yu Y, Xu J, Shu H (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet. Available: https://doi.org/10.1016/S2213-2600(20)30079-5
    DOI  |   Google Scholar
  3. Cui J, Li F, Shi ZL. (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 17(3):181-192. doi:10.1038/s41579-018-0118-9.
    DOI  |   Google Scholar
  4. World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care. Geneva: World Health Organization; 2014 Available from: https://apps.who.int/iris/bitstream/handle/10665/112656/9789241507134_eng.pdf?sequence=1.
     Google Scholar
  5. Ong SW, Tan YK, Chia PY, Lee TH, Ng OT, Wong MS, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020 Mar 4 [Epub ahead of print].
    DOI  |   Google Scholar
  6. Zhang Y, Chen C, Zhu S et al. [Isolation of 2019-nCoV from a stool specimen of a laboratory-confirmed case of the coronavirus disease 2019 (COVID-19)]. China CDC Weekly. 2020;2(8):123–4. (In Chinese).
    DOI  |   Google Scholar
  7. J. F.-W. Chan, S. Yuan, K.-H. Kok, K. K.-W. To, H. Chu and J. Yang, "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. [Online]. Available: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30154-9/fulltext.
     Google Scholar
  8. Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med. 2012;40(5):1487-1498. doi:10.1097/CCM.0b013e3182416f23
    DOI  |   Google Scholar
  9. J. Cohen, W. Powderly and S. Opal, Infectious Disease (Fourth Edition), Elsevier, 2016.
     Google Scholar
  10. Patel, J. A., Nielsen, F., Badiani, A. A., Assi, S., Unadkat, V. A., Patel, B., Ravindrane, R., & Wardle, H. (2020). Poverty, inequality and COVID-19: the forgotten vulnerable. Public health, 183, 110–111.
    DOI  |   Google Scholar
  11. World Health Organization, Laboratory testing for coronavirus disease, March 2020.
     Google Scholar
  12. Nakiyingi, L., Nankabirwa, H., & Lamorde, M. (2013). Tuberculosis diagnosis in resource-limited settings: Clinical use of GeneXpert in the diagnosis of smear-negative PTB: a case report. African health sciences, 13(2), 522–524.
    DOI  |   Google Scholar
  13. Abong, J., Dalay, V., Langley, I., Tomeny, E., Marcelo, D., Mendoza, V., Aquino, A. C., Garfin, A., Squire, B., & Yu, C. (2019). Use of GeneXpert and the role of an expert panel in improving clinical diagnosis of smear-negative tuberculosis cases. PloS one, 14(12), e0227093.
    DOI  |   Google Scholar
  14. K. C. C. J. B. a. S. M. Geo. Brooks, Jawetz, Melnick & Adelbergs Medical Microbiology, Lange.
     Google Scholar
  15. Karnad, A., Alvarez, S., & Berk, S. L. (1987). Enterobacter pneumonia. Southern medical journal, 80(5), 601–604.
    DOI  |   Google Scholar
  16. M. V. Villegas and J. P. Quinn, "Enterobacter species," [Online] Available: http://www.antimicrobe.org/b97.asp#:~:text=Like%20other%20enteric%20gram%2Dnegative,meningitis%20(4%2C%2039).
     Google Scholar
  17. Dwivedi, M; Mishra, A; Singh, RK; Azim, A; Baronia, AK; Prasad, KN (2009). Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit. Indian Journal of Pathology and Microbiology.
     Google Scholar
  18. World Health Organization, "Hospital Hygiene & Infection Control," [Online]. Available: https://www.who.int/docstore/water_sanitation_health/wastemanag/ch16.htm#b3-14.3.%20The%20prevention%20of%20nosocomial%20infection.
     Google Scholar
  19. R. TM, M. LSP, Z. N, R. N, S. K, G. M, S. G, C. G and H. A. (2020). Bacterial and Fungal Coinfection in Individuals with Coronavirus: A Rapid Review to Support COVID-19 Antimicrobial Prescribing. [Online]. Available: https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa530/5828058.
     Google Scholar
  20. Chih-Cheng Lai, Cheng-Yi Wang, Po-Ren Hsueh. (2020) Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents. Journal of Microbiology, Immunology and Infection. ISSN 1684-1182.
     Google Scholar
  21. Singhal T. (2020). A Review of Coronavirus Disease-2019 (COVID-19). Indian journal of pediatrics, 87(4), 281–286.
    DOI  |   Google Scholar
  22. Cox MJ; Loman N; Bogaert D; O'Grady J. (2020) Co-infections: potentially lethal and unexplored in COVID-19. The Lancet. https://doi.org/10.1016/S2666-5247(20)30009-4.
    DOI  |   Google Scholar


Most read articles by the same author(s)